Literature DB >> 10419032

Fate of cartilage material used in middle ear surgery light and electron microscopy study.

M Hamed1, M Samir, M El Bigermy.   

Abstract

OBJECTIVE: To evaluate the fate of autograft and homograft cartilage used in the middle ear.
METHOD: Animal experimental study was carried out on 20 healthy guinea pigs by implanting small pieces of auto- and homograft costal cartilage in the middle ears for different periods of time (1, 3 and 6 months). The grafts were removed and examined by light and electron microscopy. Cartilage autografts, obtained from seven human cases at revision tympanoplasty, were also examined by light and electron microscopy.
RESULTS: In the animal experimental study the chondrocytes were degenerated while the matrix was preserved in both auto- and homograft specimens. The homografts were as good as the autografts as in both cases the cartilage matrix was preserved. In the human specimens obtained after 10-15 months of implantation (six cases), the matrix was preserved, the lacunae were empty and the chondrocytes were degenerated. The specimen removed after 31/2 years (one case) showed viable chondrocytes of big size with defined cell organelles.
CONCLUSION: This work provides evidence for the beneficial role of cartilage in middle ear surgery as the matrix retained its structure. There is also a possibility for the chondrocytes to remain viable for a long time after implantation. It seems also that homograft cartilage is a good option during tympanoplasty and is comparable to autografts. In the animal study the homografts were as good as the autografts as in both cases cartilage matrix was preserved.

Entities:  

Mesh:

Year:  1999        PMID: 10419032     DOI: 10.1016/s0385-8146(99)00012-7

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  9 in total

1.  It is prudent to consider use of endoscopic tympanoplasty to treat complicated middle-ear disease.

Authors:  Zhengcai Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-12       Impact factor: 2.503

2.  Comparative Study of Hearing Improvement of Type 1 Tympanoplasty Using Temporalis Fascia and Conchal Cartilage as Graft Material.

Authors:  Bhanu Bhardwaj; Jaskaran Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-02-09

3.  A Comparative Study of Type-I Underlay Tympanoplasty with Temporalis Fascia Graft Alone and with Conchal Cartilage.

Authors:  Vinson Louis Gonzaga Fernandes; H C Goel; Ehrlson De Sousa; Nina Margarida De Gouveia Pinto
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-11

Review 4.  [Reconstruction of the tympanic membrane applying cartilage: indications, techniques and results].

Authors:  A Neumann; K Jahnke
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

5.  Endoscopic Tympanoplasty Using Nasal Septal Cartilage Allograft.

Authors:  N Ahilasamy; Badra Shanti; Sivaprakasam Rajasekaran
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-13

6.  Tragal cartilage in tympanoplasty: anatomic and functional results in 306 cases.

Authors:  M Cavaliere; G Mottola; M Rondinelli; M Iemma
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-02       Impact factor: 2.124

7.  Cartilage graft or fascia in tympanoplasty in patients with low middle ear risk index (anatomical and audological results).

Authors:  Elif Ersoy Callioglu; B Tijen Ceylan; Gokhan Kuran; Sule Demirci; Kamil Gokce Tulaci; Refik Caylan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-25       Impact factor: 2.503

8.  The audiological and take results of perichondrium attached cartilage island graft in tympanoplasty: PACIT.

Authors:  F Solmaz; D Akduman; M Haksever; E Gündoğdu; M Yanılmaz; A Mescioğlu
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

9.  A Short-term Comparison Between Result of Palisade Cartilage Tympanoplasty and Temporalis Fascia Technique.

Authors:  Mahmood Shishegar; Abolhasan Faramarzi; Ayeh Taraghi
Journal:  Iran J Otorhinolaryngol       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.